Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Life Course Socioeconomic Status, Allostatic Load, and Kidney Health in Black Americans.

Lunyera J, Stanifer JW, Davenport CA, Mohottige D, Bhavsar NA, Scialla JJ, Pendergast J, Boulware LE, Diamantidis CJ.

Clin J Am Soc Nephrol. 2020 Mar 6;15(3):341-348. doi: 10.2215/CJN.08430719. Epub 2020 Feb 19.

PMID:
32075808
2.

Markers of mineral metabolism and vascular access complications: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.

Gardezi AI, Karim MS, Rosenberg JE, Scialla JJ, Banerjee T, Powe NR, Shafi T, Parekh RS, Yevzlin AS, Astor BC.

Hemodial Int. 2020 Jan;24(1):43-51. doi: 10.1111/hdi.12798. Epub 2019 Dec 1.

PMID:
31789482
3.

Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Isakova T, Cai X, Lee J, Mehta R, Zhang X, Yang W, Nessel L, Anderson AH, Lo J, Porter A, Nunes JW, Negrea L, Hamm L, Horwitz E, Chen J, Scialla JJ, de Boer IH, Leonard MB, Feldman HI, Wolf M; CRIC Study Investigators.

Am J Kidney Dis. 2020 Feb;75(2):235-244. doi: 10.1053/j.ajkd.2019.07.022. Epub 2019 Oct 23.

PMID:
31668375
4.

Serum Calcification Propensity and Clinical Events in CKD.

Bundy JD, Cai X, Mehta RC, Scialla JJ, de Boer IH, Hsu CY, Go AS, Dobre MA, Chen J, Rao PS, Leonard MB, Lash JP, Block GA, Townsend RR, Feldman HI, Smith ER, Pasch A, Isakova T; CRIC Study Investigators.

Clin J Am Soc Nephrol. 2019 Nov 7;14(11):1562-1571. doi: 10.2215/CJN.04710419. Epub 2019 Oct 28.

PMID:
31658949
5.

DASH Diet and Blood Pressure Among Black Americans With and Without CKD: The Jackson Heart Study.

Tyson CC, Davenport CA, Lin PH, Scialla JJ, Hall R, Diamantidis CJ, Lunyera J, Bhavsar N, Rebholz CM, Pendergast J, Boulware LE, Svetkey LP.

Am J Hypertens. 2019 Sep 24;32(10):975-982. doi: 10.1093/ajh/hpz090.

PMID:
31187128
6.

Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease.

Hein AM, Scialla JJ, Edmonston D, Cooper LB, DeVore AD, Mentz RJ.

JACC Heart Fail. 2019 May;7(5):371-382. doi: 10.1016/j.jchf.2019.02.009. Review.

PMID:
31047016
7.

Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.

Bundy JD, Cai X, Scialla JJ, Dobre MA, Chen J, Hsu CY, Leonard MB, Go AS, Rao PS, Lash JP, Townsend RR, Feldman HI, de Boer IH, Block GA, Wolf M, Smith ER, Pasch A, Isakova T; CRIC Study Investigators.

Am J Kidney Dis. 2019 Jun;73(6):806-814. doi: 10.1053/j.ajkd.2019.01.024. Epub 2019 Mar 29.

PMID:
30935773
8.

Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study.

Brown L, Luciano A, Pendergast J, Khairallah P, Anderson CAM, Sondheimer J, Hamm LL, Ricardo AC, Rao P, Rahman M, Miller ER 3rd, Sha D, Xie D, Feldman HI, Asplin J, Wolf M, Scialla JJ; CRIC Study Investigators.

Am J Kidney Dis. 2019 Aug;74(2):203-212. doi: 10.1053/j.ajkd.2018.12.043. Epub 2019 Mar 22.

PMID:
30910373
9.

Evaluation of Allostatic Load as a Mediator of Sleep and Kidney Outcomes in Black Americans.

Lunyera J, Davenport CA, Jackson CL, Johnson DA, Bhavsar NA, Sims M, Scialla JJ, Stanifer JW, Pendergast J, McMullan CJ, Ricardo AC, Boulware LE, Diamantidis CJ.

Kidney Int Rep. 2018 Dec 18;4(3):425-433. doi: 10.1016/j.ekir.2018.12.005. eCollection 2019 Mar.

10.

Revamping the 'renal' diet: using foods to control phosphorus physiology.

Scialla JJ, Lin PH.

Nephrol Dial Transplant. 2019 Oct 1;34(10):1619-1622. doi: 10.1093/ndt/gfz019. No abstract available.

PMID:
30805628
11.

Modifiers of Plasma 25-Hydroxyvitamin D and Chronic Kidney Disease Outcomes in Black Americans: The Jackson Heart Study.

Lunyera J, Davenport CA, Pendergast J, Musani SK, Bhavsar NA, Sims M, Mwasongwe S, Wolf M, Diamantidis CJ, Boulware LE, Scialla JJ.

J Clin Endocrinol Metab. 2019 Jun 1;104(6):2267-2276. doi: 10.1210/jc.2018-01747.

12.

Are low-carbohydrate diets safe in diabetic and nondiabetic chronic kidney disease?

Mitchell NS, Scialla JJ, Yancy WS Jr.

Ann N Y Acad Sci. 2020 Feb;1461(1):25-36. doi: 10.1111/nyas.13997. Epub 2019 Jan 15. Review.

PMID:
30644556
13.

Vitamin D Receptor Agonists for Patients Undergoing Hemodialysis.

Hall RK, Scialla JJ.

JAMA. 2018 Dec 11;320(22):2319-2321. doi: 10.1001/jama.2018.17477. No abstract available.

PMID:
30535205
14.

Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease.

Lunyera J, Scialla JJ.

Semin Nephrol. 2018 Nov;38(6):542-558. doi: 10.1016/j.semnephrol.2018.08.001. Review.

15.

Vascular Calcification Markers and Hemodialysis Vascular Access Complications.

Lyu B, Banerjee T, Scialla JJ, Shafi T, Yevzlin AS, Powe NR, Parekh RS, Astor BC.

Am J Nephrol. 2018;48(5):330-338. doi: 10.1159/000493549. Epub 2018 Oct 31.

PMID:
30380526
16.

The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.

Melamed ML, Chonchol M, Gutiérrez OM, Kalantar-Zadeh K, Kendrick J, Norris K, Scialla JJ, Thadhani R.

Am J Kidney Dis. 2018 Dec;72(6):834-845. doi: 10.1053/j.ajkd.2018.06.031. Epub 2018 Oct 5. Review.

17.

Dietary Phosphorus and Ambulatory Blood Pressure in African Americans: The Jackson Heart Study.

Olivo RE, Hale SL, Diamantidis CJ, Bhavsar NA, Tyson CC, Tucker KL, Carithers TC, Kestenbaum B, Muntner P, Tanner RM, Booth JN 3rd, Mwasongwe SE, Pendergast J, Boulware LE, Scialla JJ.

Am J Hypertens. 2019 Jan 1;32(1):94-103. doi: 10.1093/ajh/hpy126.

18.

Metabolic Changes with Base-Loading in CKD.

Scialla JJ, Brown L, Gurley S, Corcoran DL, Bain JR, Muehlbauer MJ, O'Neal SK, M O'Connell T, Wolf M, Melamed ML, Hostetter TH, Abramowitz MK.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1244-1246. doi: 10.2215/CJN.01830218. Epub 2018 Jun 22. No abstract available.

19.

Evidence basis for integrated management of mineral metabolism in patients with end-stage renal disease.

Scialla JJ.

Curr Opin Nephrol Hypertens. 2018 Jul;27(4):258-267. doi: 10.1097/MNH.0000000000000417. Review.

20.

Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.

Isakova T, Cai X, Lee J, Xie D, Wang X, Mehta R, Allen NB, Scialla JJ, Pencina MJ, Anderson AH, Talierco J, Chen J, Fischer MJ, Steigerwalt SP, Leonard MB, Hsu CY, de Boer IH, Kusek JW, Feldman HI, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

J Am Soc Nephrol. 2018 Feb;29(2):579-590. doi: 10.1681/ASN.2017070772. Epub 2017 Nov 22.

21.

Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.

Olivo RE, Davenport CA, Diamantidis CJ, Bhavsar NA, Tyson CC, Hall R, Bidulescu A, Young B, Mwasongwe SE, Pendergast J, Boulware LE, Scialla JJ.

Nephrol Dial Transplant. 2018 Jun 1;33(6):992-1001. doi: 10.1093/ndt/gfx230.

22.

Acid Load and Phosphorus Homeostasis in CKD.

Khairallah P, Isakova T, Asplin J, Hamm L, Dobre M, Rahman M, Sharma K, Leonard M, Miller E 3rd, Jaar B, Brecklin C, Yang W, Wang X, Feldman H, Wolf M, Scialla JJ; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

Am J Kidney Dis. 2017 Oct;70(4):541-550. doi: 10.1053/j.ajkd.2017.04.022. Epub 2017 Jun 21.

23.

Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets.

Olivo RE, Scialla JJ.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):868-870. doi: 10.2215/CJN.04380417. Epub 2017 May 26. No abstract available.

24.

The Authors Reply.

Scialla JJ, Asplin J, Wolf M; Chronic Renal Insufficiency Cohort Study Investigators.

Kidney Int. 2017 Jun;91(6):1518-1519. doi: 10.1016/j.kint.2017.02.020. No abstract available.

PMID:
28501306
25.

Role of Acid-Base Homeostasis in Diabetic Kidney Disease.

Khairallah P, Scialla JJ.

Curr Diab Rep. 2017 Apr;17(4):28. doi: 10.1007/s11892-017-0855-6. Review.

PMID:
28343312
26.

Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices.

Shafi T, Sozio SM, Luly J, Bandeen-Roche KJ, St Peter WL, Ephraim PL, McDermott A, Herzog CA, Crews DC, Scialla JJ, Tangri N, Miskulin DC, Michels WM, Jaar BG, Zager PG, Meyer KB, Wu AW, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Medicine (Baltimore). 2017 Feb;96(5):e5924. doi: 10.1097/MD.0000000000005924.

27.

Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.

Munoz Mendoza J, Isakova T, Cai X, Bayes LY, Faul C, Scialla JJ, Lash JP, Chen J, He J, Navaneethan S, Negrea L, Rosas SE, Kretzler M, Nessel L, Xie D, Anderson AH, Raj DS, Wolf M; CRIC Study Investigators.

Kidney Int. 2017 Mar;91(3):711-719. doi: 10.1016/j.kint.2016.10.021. Epub 2016 Dec 22.

28.

Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes.

Scialla JJ, Asplin J, Dobre M, Chang AR, Lash J, Hsu CY, Kallem RR, Hamm LL, Feldman HI, Chen J, Appel LJ, Anderson CA, Wolf M; Chronic Renal Insufficiency Cohort Study Investigators.

Kidney Int. 2017 Jan;91(1):204-215. doi: 10.1016/j.kint.2016.09.012. Epub 2016 Dec 1.

29.

Intravenous iron administration strategies and anemia management in hemodialysis patients.

Michels WM, Jaar BG, Ephraim PL, Liu Y, Miskulin DC, Tangri N, Crews DC, Scialla JJ, Shafi T, Sozio SM, Bandeen-Roche K, Cook CJ, Meyer KB, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Nephrol Dial Transplant. 2017 Jan 1;32(1):173-181. doi: 10.1093/ndt/gfw316.

30.

Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.

Mehta R, Cai X, Lee J, Scialla JJ, Bansal N, Sondheimer JH, Chen J, Hamm LL, Ricardo AC, Navaneethan SD, Deo R, Rahman M, Feldman HI, Go AS, Isakova T, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

JAMA Cardiol. 2016 Aug 1;1(5):548-56. doi: 10.1001/jamacardio.2016.1445.

31.

Genetic African Ancestry and Markers of Mineral Metabolism in CKD.

Gutiérrez OM, Parsa A, Isakova T, Scialla JJ, Chen J, Flack JM, Nessel LC, Gupta J, Bellovich KA, Steigerwalt S, Sondheimer JH, Wright JT Jr, Feldman HI, Kusek JW, Lash JP, Wolf M.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):653-62. doi: 10.2215/CJN.08020715. Epub 2016 Feb 8.

32.

Food Access, Chronic Kidney Disease, and Hypertension in the U.S.

Suarez JJ, Isakova T, Anderson CA, Boulware LE, Wolf M, Scialla JJ.

Am J Prev Med. 2015 Dec;49(6):912-20. doi: 10.1016/j.amepre.2015.07.017.

33.

Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.

Chen TK, Choi MJ, Kao WH, Astor BC, Scialla JJ, Appel LJ, Li L, Lipkowitz MS, Wolf M, Parekh RS, Winkler CA, Estrella MM, Crews DC.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2128-35. doi: 10.2215/CJN.05220515. Epub 2015 Oct 1.

34.

Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.

Scialla JJ, Parekh RS, Eustace JA, Astor BC, Plantinga L, Jaar BG, Shafi T, Coresh J, Powe NR, Melamed ML.

Am J Nephrol. 2015;42(1):25-34. doi: 10.1159/000438999. Epub 2015 Aug 20.

35.

When there will never be a randomized controlled trial.

Scialla JJ, Wolf M.

Kidney Int. 2015 Aug;88(2):220-2. doi: 10.1038/ki.2015.123.

36.
37.

Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.

Scialla JJ.

Curr Opin Nephrol Hypertens. 2015 May;24(3):260-7. doi: 10.1097/MNH.0000000000000123. Review.

38.

Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial.

Isakova T, Craven TE, Scialla JJ, Nickolas TL, Schnall A, Barzilay J, Schwartz AV; Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.

Bone. 2015 Sep;78:23-7. doi: 10.1016/j.bone.2015.04.037. Epub 2015 Apr 30.

39.

Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study.

Dobre M, Yang W, Pan Q, Appel L, Bellovich K, Chen J, Feldman H, Fischer MJ, Ham LL, Hostetter T, Jaar BG, Kallem RR, Rosas SE, Scialla JJ, Wolf M, Rahman M; CRIC Study Investigators.

J Am Heart Assoc. 2015 Apr 20;4(4). pii: e001599. doi: 10.1161/JAHA.114.001599.

40.

Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.

Tangri N, Miskulin DC, Zhou J, Bandeen-Roche K, Michels WM, Ephraim PL, McDermott A, Crews DC, Scialla JJ, Sozio SM, Shafi T, Jaar BG, Meyer K, Boulware LE; DEcIDE Network Patient Outcomes in End-Stage Renal Disease Study Investigators.

Nephrol Dial Transplant. 2015 Apr;30(4):667-75. doi: 10.1093/ndt/gfu349. Epub 2014 Nov 2.

41.

Fibroblast growth factor 23 and incident CKD in type 2 diabetes.

Isakova T, Craven TE, Lee J, Scialla JJ, Xie H, Wahl P, Marcovina SM, Byington RP, Wolf M.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):29-38. doi: 10.2215/CJN.06190614. Epub 2014 Oct 24.

42.

Intravenous iron exposure and mortality in patients on hemodialysis.

Miskulin DC, Tangri N, Bandeen-Roche K, Zhou J, McDermott A, Meyer KB, Ephraim PL, Michels WM, Jaar BG, Crews DC, Scialla JJ, Sozio SM, Shafi T, Wu AW, Cook C, Boulware LE; Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1930-9. doi: 10.2215/CJN.03370414. Epub 2014 Oct 15.

43.

Incidental findings on cardiac computed tomography in incident hemodialysis patients: the predictors of arrhythmic and cardiovascular events in end-stage renal disease (PACE) study.

Jaar BG, Zhang L, Chembrovich SV, Sozio SM, Shafi T, Scialla JJ, Tomaselli GF, Lima JA, Kao WH, Parekh RS, Meoni LA.

BMC Nephrol. 2014 May 1;15:68. doi: 10.1186/1471-2369-15-68.

44.

An instrumental variable approach finds no associated harm or benefit with early dialysis initiation in the United States.

Scialla JJ, Liu J, Crews DC, Guo H, Bandeen-Roche K, Ephraim PL, Tangri N, Sozio SM, Shafi T, Miskulin DC, Michels WM, Jaar BG, Wu AW, Powe NR, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Kidney Int. 2014 Oct;86(4):798-809. doi: 10.1038/ki.2014.110. Epub 2014 Apr 30. Erratum in: Kidney Int. 2016 Apr;89(4):957. Kim, Jeonyong [corrected to Kim, Jeongyong].

45.

Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.

Scialla JJ, Wolf M.

Nat Rev Nephrol. 2014 May;10(5):268-78. doi: 10.1038/nrneph.2014.49. Epub 2014 Apr 1. Review.

PMID:
24686452
46.

Comparative effectiveness of early versus conventional timing of dialysis initiation in advanced CKD.

Crews DC, Scialla JJ, Boulware LE, Navaneethan SD, Nally JV Jr, Liu X, Arrigain S, Schold JD, Ephraim PL, Jolly SE, Sozio SM, Michels WM, Miskulin DC, Tangri N, Shafi T, Wu AW, Bandeen-Roche K; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

Am J Kidney Dis. 2014 May;63(5):806-15. doi: 10.1053/j.ajkd.2013.12.010. Epub 2014 Feb 6.

47.

Biomarkers of vascular calcification and mortality in patients with ESRD.

Scialla JJ, Kao WH, Crainiceanu C, Sozio SM, Oberai PC, Shafi T, Coresh J, Powe NR, Plantinga LC, Jaar BG, Parekh RS.

Clin J Am Soc Nephrol. 2014 Apr;9(4):745-55. doi: 10.2215/CJN.05450513. Epub 2014 Jan 23.

48.

Predialysis systolic BP variability and outcomes in hemodialysis patients.

Shafi T, Sozio SM, Bandeen-Roche KJ, Ephraim PL, Luly JR, St Peter WL, McDermott A, Scialla JJ, Crews DC, Tangri N, Miskulin DC, Michels WM, Jaar BG, Herzog CA, Zager PG, Meyer KB, Wu AW, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

J Am Soc Nephrol. 2014 Apr;25(4):799-809. doi: 10.1681/ASN.2013060667. Epub 2014 Jan 2.

49.

Kidney allograft survival of African American and Caucasian American recipients with lupus.

Contreras G, Li H, Gonzalez-Suarez M, Isakova T, Scialla JJ, Pedraza F, Mattiazzi A, Diaz-Wong R, Sageshima J, Brito Y, Guerra G, Acevedo B, Sajid Ali A, Kershaw TJ, Chen L, Burke GW, Kupin W, Ciancio G, Roth D.

Lupus. 2014 Feb;23(2):151-8. doi: 10.1177/0961203313513819. Epub 2013 Dec 2.

PMID:
24297643
50.

Trends in anemia management in US hemodialysis patients 2004-2010.

Miskulin DC, Zhou J, Tangri N, Bandeen-Roche K, Cook C, Ephraim PL, Crews DC, Scialla JJ, Sozio SM, Shafi T, Jaar BG, Boulware LE; DEcIDE Network Patient Outcomes in End Stage Renal Disease Study Investigators.

BMC Nephrol. 2013 Dec 1;14:264. doi: 10.1186/1471-2369-14-264.

Supplemental Content

Loading ...
Support Center